During the period 1 January to 31 December 2003 the following rules shall apply:
the allocation of essential medical use quotas for chlorofluorocarbons 11, 12, 113, 114 and 115 shall be to the companies indicated in Annex II;
the allocation of essential laboratory use quotas for chlorofluorocarbons 11, 12, 113, 114 and 115 and other fully halogenated chlorofluorocarbons shall be to the companies indicated in Annex III;
the allocation of essential laboratory use quotas for halons shall be to the companies indicated in Annex IV;
the allocation of essential laboratory use quotas for carbon tetrachloride shall be to the companies indicated in Annex V;
the allocation of essential laboratory use quotas for 1,1,1-trichloroethane shall be to the companies indicated in Annex VI;
the allocation of essential laboratory use quotas for hydrobromofluorocarbons shall be to the companies indicated in Annex VII;
the allocation of essential laboratory use quotas for bromochloromethane shall be to the companies indicated in Annex VIII;
the essential use quotas for chlorofluorocarbons 11, 12, 113, 114 and 115, other fully halogenated chlorofluorocarbons, carbon tetrachloride, 1,1,1-trichloroethane, hydrobromofluorocarbons and bromochloromethane shall be as set out in Annex IX.